Presentation of Biovitrum's Interim Report January - September 2009 -
October 22
(Thomson Reuters ONE) - Biovitrum would like to invite you to a media and investor meeting inStockholm on Thursday, October 22, in conjunction with theannouncement of the Interim Report for the third quarter and firstnine month 2009.The report will be presented by Biovitrum's CEO Martin Nicklasson andCFO Göran Arvidson. The presentation will be held in English andwebcasted. Time: Thursday, October 22, 2009 at 10 a.m. (CET) Venue: Scandic Anglais, Humlegårdsgatan 23, Stockholm Coffee will be servedThe report will be published at 8.00 a.m. (CET) the same day.Registration:Please register for participation to Mikael Nilimaa onmikael.nilimaa(at)zoomvision.se or by telephone +46 702 699 322.Webcast:The presentation will be webcast, October 22 at 10 a.m. (CET):www.biovitrum.com.Telephone dial in: UK: + 44 208 817 9301, Swe: +46 (0) 850 520 270,US:+ 1 718 354 1226___________________________________________________________________Telephone conference call:For media and investors in other time zones a summary presentationand Q&A session will be held.Time: Thursday, October 22, 2009 at 3 p.m. (CET)Dial-in numbers:UK: + 44 208 817 9301Swe: +46 (0) 850 520 270US: + 1 718 354 1226___________________________________________________________________The presentation material will be published on our web site after themeeting as will the archived web cast, please go to:www.biovitrum.com.Welcome!Erik Kinnman, EVP Investor RelationsPhone: +46 8 697 21 50, erik.kinnman(at)biovitrum.comAbout BiovitrumBiovitrum is an international pharmaceutical company that marketsspecialist pharmaceuticals in several regions. Using its expertiseand experience Biovitrum takes scientific innovation to patients withsignificant unmet medical need. Research expertise and capabilitiesare focused on development and production of biotechnologytherapeutics within our prioritized areas of hemophilia,inflammation/autoimmune diseases, cancer supportive care andmalabsorption. The company has revenues of approximately SEK 1.2billion and around 400 employees. The company head office is locatedin Sweden and it is listed on the Stockholm OMX Nordic Exchange. Formore information please visit www.biovitrum.comhttp://hugin.info/134557/R/1348686/324671.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 20.10.2009 - 14:06 Uhr
Sprache: Deutsch
News-ID 7131
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Presentation of Biovitrum's Interim Report January - September 2009 -
October 22"
steht unter der journalistisch-redaktionellen Verantwortung von
Biovitrum (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
